Press Releases

Varian Provides an Update on Expected Impact From COVID-19

Varian (NYSE: VAR) today announced that the COVID-19 outbreak will negatively impact the company's operating results. Across the company's Asia-Pacific geographies, healthcare resources are being...

Varian to Attend Upcoming Investor Events

Varian (NYSE: VAR) today announced that J. Michael Bruff, chief financial officer and Anshul Maheshwari, vice president, investor relations and treasurer will be participating in the following...

Varian Receives FDA 510(k) Clearance for Ethos Therapy

Varian (NYSE: VAR) today announced it has received FDA 510(k) clearance for its Ethos™ therapy, an Adaptive Intelligence™ solution. Ethos therapy is an artificial intelligence (AI)-driven...

Massachusetts General Hospital Selects Varian Radiotherapy Systems for Cancer Center

Varian (NYSE: VAR) today announced it has signed an agreement with Massachusetts General Hospital to provide seven Varian radiotherapy systems and related services for advanced cancer treatment at...

Varian Reports Results for First Quarter of Fiscal Year 2020

First Quarter 2020 Summary Oncology Systems gross orders grew 8% in dollars or 9% in constant currency in the quarter and over the trailing twelve months Total company revenues grew 12% in...

Varian Appoints Prof. Dr. Ricky Sharma VP of Clinical Affairs

Varian (NYSE: VAR) today announced it has appointed Dr. Ricky Sharma, to vice president of Clinical Affairs. In this role he will be leading medical research, translational science and clinical...

Varian to Present at the J.P. Morgan Healthcare Conference

Varian (NYSE: VAR) today announced that Dow Wilson, chief executive officer, and Chris Toth, president of Oncology Systems, will present at the J.P. Morgan Healthcare Conference in San Francisco,...

Varian Announces First Quarter Fiscal Year 2020 Earnings Release Date

Varian (NYSE: VAR) today announced its first quarter fiscal year 2020 earnings release date. The Company will report results for the first quarter of fiscal year 2020 after market close on...

Varian Schedules Annual Stockholder Meeting in Palo Alto

Varian (NYSE: VAR) today announced that its Board of Directors has scheduled the 2020 Annual Meeting of Stockholders for February 13, 2020 with a record date of December 16, 2019. The meeting will...

Varian Further Expands Access to Care in Africa to Address Growing Cancer Burden

According to the World Health Organization, the number of new cancer cases diagnosed per year in Africa is expected to grow from over 1 million in 2018 to over 2.1 million in 2040. Continuing its...